Similar Stories to Eisai, Eli Lilly Didn't Disclose Heightened Brain Injury Risk To Alzheimer's Trial Patients: Nyt - Fierce Biotech on Bing News

Eisai, Eli Lilly didn't disclose heightened brain injury risk to Alzheimer's trial patients: NYT Fierce BiotechView Full Coverage on Google News

BING NEWS:
  • Eisai, Eli Lilly didn't disclose heightened brain injury risk to Alzheimer's trial patients: NYT
    A new bombshell has been dropped in the scandal-plagued world of Alzheimer’s disease drug development. | Between the two companies, more than 560 people joined trials without being told they had a ...
    10/24/2024 - 4:33 am | View Link
  • What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
    Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
    10/23/2024 - 3:19 am | View Link
  • Eisai's full lecanemab phase 3 trial results for Alzheimer's presented at CTAD
    Last month, Roche’s Genentech division reported disappointing top-line results from its highly-anticipated phase 3 trial of gantenerumab in early Alzheimer’s disease, in yet another setback ...
    10/15/2024 - 12:59 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News